Variant's VAR002 receives positive European regulatory feedback
Amgen's UPLIZNA receives US FDA approval for IgG4-RD
Sanofi's rilzabrutinib receives US orphan drug designation for two rare diseases
Hoth Therapeutics partners with Washington University to advance Alzheimer's disease research
Mabwell's B7-H3-targeting ADC clinical trial application receives Chinese regulatory approval
Amygdala Neurosciences selects ANS-858 as lead clinical candidate for substance use disorder
Quest Diagnostics expands HPV self-collection screening option
Ondine Biomedical's Steriwave technology reduces surgical site infections by 71% in NHS deployment
GRIN Therapeutics' radiprodil granted Priority Medicine designation in Europe
Yingli Pharma's linperlisib Phase 3 registration study approved by US FDA